Cue Biopharma (CUE) Shares Outstanding (Entity) (2017 - 2026)
Cue Biopharma's Shares Outstanding (Entity) came in at 5.23 million for Q2 2026, down 93.2% from 76.45 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
For FY2025, Cue Biopharma's Shares Outstanding (Entity) was 96.62 million, up 56.3% from FY2024.
- Shares Outstanding (Entity) has increased in each of the last eight years, with a five-year compound annual growth rate of 26.1% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 61.82 million in FY2024 (+30.9%), 47.22 million in FY2023 (+32.4%), 35.65 million in FY2022 (+10.7%) and 32.2 million in FY2021 (+6.1%).
- The Q2 2026 figure represents the lowest quarterly Shares Outstanding (Entity) in data going back to Q1 2017.
- Year-over-year, Shares Outstanding (Entity) increased in six of the last seven quarters, with growth averaging 25.6%.
- The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q3 2025 (growth of 67.5%), and the weakest in Q2 2026 (a decline of 93.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Cue Biopharma | 121.14 Mn | 30.41 Mn | - | 5.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.23 Mn |
| Dec 31, 2025 | 96.62 Mn |
| Sep 30, 2025 | 100.87 Mn |
| Jun 30, 2025 | 76.45 Mn |
| Mar 31, 2025 | 61.82 Mn |
| Dec 31, 2024 | 61.82 Mn |
| Sep 30, 2024 | 60.21 Mn |
| Jun 30, 2024 | 48.64 Mn |
| Mar 31, 2024 | 48.64 Mn |
| Dec 31, 2023 | 47.22 Mn |
| Sep 30, 2023 | 45.12 Mn |
| Jun 30, 2023 | 43.74 Mn |
| Mar 31, 2023 | 43.18 Mn |
| Dec 31, 2022 | 35.65 Mn |
| Sep 30, 2022 | 35.39 Mn |
| Jun 30, 2022 | 35.38 Mn |
| Mar 31, 2022 | 34.17 Mn |
| Dec 31, 2021 | 32.20 Mn |
| Sep 30, 2021 | 31.36 Mn |
| Jun 30, 2021 | 31.47 Mn |
API Access
Cue Biopharma Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();